signincomeonin Portfolio 1
486 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by signincomeonin
DESCRIPTION:

Date updated:05-31-2007

Biotech

symbol name last price % change open
  • +
  • ENMD
    Entremed
  • $1.06
  • -2.75%
  • $1.01

ealy stage clinical biotech with 15 Phase2 clinical trials of 3 diffrent drugs: PanzemNCD (2ME2 nanocrytaldispersion); MKC-1, ENMD=-1198. Drugs have multimechanisms of action and are being used for a multiplicity of cancers( glioblastoma multiforme, nslc-lung-, ovarian, kidney, multiple myeloma, prostate, advanced cancers, and Panzem is slated to be used also in inflammatory diseases, most notably rheumatoid arthritis. Celgene owns 27.22% ofd voting stock, large ownership by insiders and institutions; cash on hand to go well into second half of 2008 with no debt. An ambitoius program with an administration which in the past 2 yers has met its deadliners on time; multiple other drugs in pipeline; impending partnership for its aurura kinase inhibitor with Big Pharma company . Will be presenting 3 papers at ASCO June 1 through June 6, 2007 Currently unknown and underpriced

People owning ENMD also tend to own: 0001.HKAMXAVGNCIPHINGNOEC.AXTGEN

TheStreet.com Rating: D What is this?

  • +
  • CELG
    Celgene Corporati
  • $53.05
  • +2.35%
  • $51.57

celgene- need I say more; a very early investor and have hung on since for the rewarding ride (up more than 5,300% in the past 10 yrs)

People owning CELG also tend to own: GTIACIRADSTXNVARASHBNI

TheStreet.com Rating: B- What is this?

  • +
  • ARIA
    Ariad Pharmaceuti
  • $2.17
  • +9.60%
  • $1.97

a sleeper biotech- will be running Phase 3 trials for bone cancer

People owning ARIA also tend to own: AGIXCPSLINODKONGLTONNOECORS

TheStreet.com Rating: E+ What is this?

  • +
  • GENZ
    Genzyme Corporati
  • $52.28
  • +0.50%
  • $51.66

a real winner in niche markets

People owning GENZ also tend to own: LRCXWRLDAMGNDNAAMZNBLUDHPQ

TheStreet.com Rating: C+ What is this?

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

This Week's 'Barron's' Roundup

By Roberto Pedone Posted on Nov. 9, 2009 Financial-Services Bull: Barron’s talks with Anton Schutz, portfolio manager at the Burnham Financial Industries Fund (BURFX)...

11.09.09 | 11:01 AM
Rocket Stocks for the Week

By Jonas Elmerraji Posted on Nov. 9, 2009 Last week brought investors a welcome return to gains as the S&P 500 pushed up 3.2% over the course of the last five trading d...

11.09.09 | 08:04 AM
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...

11.06.09 | 15:52 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...

11.05.09 | 12:05 PM
more articles
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Wealth distribution by race and ...
11.23.08 | 18:44 PM From author Valerie J
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
Full Disclosure
11.09.08 | 12:30 PM From author alchemist
more forums
Q. Can anyone explain the rationale...
11.09.09 | 16:00 PM Asked by flyers44

A. Central banks across the globe joined
Bernenke in announcing continued low
interest rates. Meanwhile, banks can
keep longer-term rates high, maintaining
that steep yield curve, which is a money
machine for the banks.

today 's lists
Rising on Unusual Volume

Here are some stocks that moved up on unusual volume on Nov. 2, 2009. more

Biggest % Losers

Here is the stock list of some of the largest % losers from Nov. 2, 2009. more

52-Week Highs

Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more